Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

Company Overview - Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines aimed at curing neurological diseases [3] - The company's pipeline includes programs targeting Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and other central nervous system diseases [3] - Voyager utilizes its TRACER™ AAV capsid discovery platform to develop novel capsids for high brain penetration of genetic medicines [3] Upcoming Financial Results - Voyager Therapeutics will report its fourth quarter 2024 financial and operating results after market close on March 11, 2025 [1] - A conference call and webcast will follow at 4:30 p.m. ET on the same day [1] Investor Information - A live webcast of the conference call will be available on the Investors section of the Voyager website [2] - A replay of the call will be accessible approximately two hours after its completion and will remain available for at least 30 days [2]